Upgrade to SI Premium - Free Trial

PTC Therapeutics (PTCT)

25.79 -0.18 (0.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (4/25/24)
- M&A (Rumor)

Latest Headlines

Form 4 PTC THERAPEUTICS, INC. For: Apr 19 Filed by: Klein Matthew B. April 22, 2024 5:20 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Apr 17 Filed by: Pauwels Eric April 19, 2024 5:20 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Apr 17 Filed by: Klein Matthew B. April 19, 2024 5:20 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B. April 19, 2024 3:18 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Pauwels Eric April 17, 2024 3:24 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Klein Matthew B. April 17, 2024 3:13 PM - SEC Filing PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results April 11, 2024 8:00 AM - PR NewsWire Form 4 PTC THERAPEUTICS, INC. For: Apr 02 Filed by: Golden Lee Scott April 4, 2024 5:17 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Golden Lee Scott April 2, 2024 3:59 PM - SEC Filing PTC Therapeutics (PTCT) Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA March 28, 2024 8:32 AM - StreetInsider PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA March 28, 2024 8:30 AM - PR NewsWire PTC Therapeutics (PTCT) PT Raised to $35 at Jefferies March 20, 2024 7:42 AM - StreetInsider PTC Therapeutics (PTCT) Provides Regulatory Updates March 19, 2024 7:31 AM - StreetInsider PTC Therapeutics Provides Key Regulatory Updates March 19, 2024 7:30 AM - PR NewsWire PTC Therapeutics (PTCT) PT Lowered to $30 at TD Cowen March 1, 2024 8:31 AM - StreetInsider PTC Therapeutics (PTCT) PT Raised to $28 at RBC Capital March 1, 2024 7:26 AM - StreetInsider Form 10-K PTC THERAPEUTICS, INC. For: Dec 31 February 29, 2024 4:41 PM - SEC Filing Form 8-K PTC THERAPEUTICS, INC. For: Feb 29 February 29, 2024 4:19 PM - SEC Filing PTC Therapeutics (PTCT) Misses Q4 EPS by $2.55 February 29, 2024 4:16 PM - StreetInsider PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results February 29, 2024 4:05 PM - PR NewsWire PTC Therapeutics to Participate at Upcoming Investor Conferences February 27, 2024 5:20 PM - PR NewsWire PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 22, 2024 4:30 PM - PR NewsWire Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Utter Christine Marie February 16, 2024 5:01 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Almstead Neil Gregory February 16, 2024 5:01 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Pauwels Eric February 16, 2024 5:00 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: SCHMERTZLER MICHAEL February 16, 2024 4:26 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Bell William F. Jr. February 16, 2024 4:21 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: SOUTHWELL DAVID P February 16, 2024 4:20 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Okey Stephanie February 16, 2024 4:17 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Gravier Pierre February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Golden Lee Scott February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Klein Matthew B. February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Reeve Emma February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Boulding Mark Elliott February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Jacobson Allan Steven February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: ZELDIS JEROME B February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Young Alethia February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: STEELE GLENN JR MD PHD February 16, 2024 4:11 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Feb 15 Filed by: Smith Mary L. February 16, 2024 4:11 PM - SEC Filing PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results February 15, 2024 8:00 AM - PR NewsWire Form SC 13G PTC THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC February 14, 2024 3:51 PM - SEC Filing Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: RTW INVESTMENTS, LP February 14, 2024 7:14 AM - SEC Filing Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC February 13, 2024 6:11 PM - SEC Filing Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP February 8, 2024 10:18 AM - SEC Filing PTC Therapeutics (PTCT) PT Lowered to $43 at JPMorgan February 5, 2024 8:11 AM - StreetInsider Form 4 PTC THERAPEUTICS, INC. For: Jan 30 Filed by: Almstead Neil Gregory February 1, 2024 4:19 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Jan 30 Filed by: Boulding Mark Elliott February 1, 2024 4:18 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Jan 30 Filed by: Pauwels Eric February 1, 2024 4:17 PM - SEC Filing Form 4 PTC THERAPEUTICS, INC. For: Jan 30 Filed by: Utter Christine Marie February 1, 2024 4:16 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Boulding Mark Elliott January 30, 2024 3:31 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Pauwels Eric January 30, 2024 3:26 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Zheng Yang January 30, 2024 3:19 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory January 30, 2024 3:19 PM - SEC Filing Form 144 PTC THERAPEUTICS, INC. Filed by: Utter Christine Marie January 30, 2024 3:18 PM - SEC Filing PTC Therapeutics (PTCT) PT Lowered to $22 at RBC Capital January 26, 2024 6:47 AM - StreetInsider After-hours movers: Intel sinks after soft forecast, and more January 25, 2024 5:00 PM - StreetInsider PTC Therapeutics (PTCT) Reports Negative CHMP Opinion for Renewal of Conditional Marketing Authorization for Translarna January 25, 2024 4:07 PM - StreetInsider Form 8-K PTC THERAPEUTICS, INC. For: Jan 25 January 25, 2024 4:07 PM - SEC Filing CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure January 25, 2024 4:05 PM - PR NewsWire Form 4 PTC THERAPEUTICS, INC. For: Jan 22 Filed by: Jacobson Allan Steven January 24, 2024 4:31 PM - SEC Filing Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: STATE STREET CORP January 24, 2024 1:11 PM - SEC Filing Full Article List